Search

Juvena W. Loo

Examiner (ID: 18974, Phone: (571)270-1974 , Office: P/2473 )

Most Active Art Unit
2473
Art Unit(s)
2473, 2616, 2416, 2609
Total Applications
547
Issued Applications
438
Pending Applications
1
Abandoned Applications
108

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16523716 [patent_doc_number] => 20200397796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => METHODS OF TREATMENT OF CANCER COMPRISING CHK1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/975686 [patent_app_country] => US [patent_app_date] => 2019-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -124 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975686 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/975686
METHODS OF TREATMENT OF CANCER COMPRISING CHK1 INHIBITORS Feb 25, 2019 Abandoned
Array ( [id] => 16492357 [patent_doc_number] => 10858382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Allyl phosphine complexes of palladium and their use in catalysis [patent_app_type] => utility [patent_app_number] => 16/284841 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19502 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/284841
Allyl phosphine complexes of palladium and their use in catalysis Feb 24, 2019 Issued
Array ( [id] => 17640589 [patent_doc_number] => 20220168327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => Compounds for Treating and Preventing Net Associated Complications [patent_app_type] => utility [patent_app_number] => 17/430756 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430756
Compounds for treating and preventing net associated complications Feb 24, 2019 Issued
Array ( [id] => 18171741 [patent_doc_number] => 11571433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-07 [patent_title] => Methods for treating memory impairment and cognitive dysfunction [patent_app_type] => utility [patent_app_number] => 16/975129 [patent_app_country] => US [patent_app_date] => 2019-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6330 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975129 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/975129
Methods for treating memory impairment and cognitive dysfunction Feb 23, 2019 Issued
Array ( [id] => 14467563 [patent_doc_number] => 20190185424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/282894 [patent_app_country] => US [patent_app_date] => 2019-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282894 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/282894
Potent and selective inhibitors of monoamine transporters; method of making; and use thereof Feb 21, 2019 Issued
Array ( [id] => 16718552 [patent_doc_number] => 20210085699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => COMBINATION THERAPIES FOR TREATING CANCERS [patent_app_type] => utility [patent_app_number] => 16/971887 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13377 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971887 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971887
COMBINATION THERAPIES FOR TREATING CANCERS Feb 20, 2019 Abandoned
Array ( [id] => 16261224 [patent_doc_number] => 10752643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Tunable rare-earth fcu-metal-organic frameworks [patent_app_type] => utility [patent_app_number] => 16/280504 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 77 [patent_no_of_words] => 11067 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280504
Tunable rare-earth fcu-metal-organic frameworks Feb 19, 2019 Issued
Array ( [id] => 16261224 [patent_doc_number] => 10752643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Tunable rare-earth fcu-metal-organic frameworks [patent_app_type] => utility [patent_app_number] => 16/280504 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 77 [patent_no_of_words] => 11067 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280504
Tunable rare-earth fcu-metal-organic frameworks Feb 19, 2019 Issued
Array ( [id] => 16261224 [patent_doc_number] => 10752643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Tunable rare-earth fcu-metal-organic frameworks [patent_app_type] => utility [patent_app_number] => 16/280504 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 77 [patent_no_of_words] => 11067 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280504
Tunable rare-earth fcu-metal-organic frameworks Feb 19, 2019 Issued
Array ( [id] => 14438849 [patent_doc_number] => 20190177297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS [patent_app_type] => utility [patent_app_number] => 16/280512 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280512 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280512
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Feb 19, 2019 Issued
Array ( [id] => 16261224 [patent_doc_number] => 10752643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Tunable rare-earth fcu-metal-organic frameworks [patent_app_type] => utility [patent_app_number] => 16/280504 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 77 [patent_no_of_words] => 11067 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280504
Tunable rare-earth fcu-metal-organic frameworks Feb 19, 2019 Issued
Array ( [id] => 16876790 [patent_doc_number] => 11026910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => a- and g-truxillic acid derivatives and pharmaceutical compositions thereof [patent_app_type] => utility [patent_app_number] => 16/276920 [patent_app_country] => US [patent_app_date] => 2019-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 18977 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276920 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/276920
a- and g-truxillic acid derivatives and pharmaceutical compositions thereof Feb 14, 2019 Issued
Array ( [id] => 20356223 [patent_doc_number] => 12472202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Compositions and their use in the treatment of endometriosis and pain [patent_app_type] => utility [patent_app_number] => 16/968696 [patent_app_country] => US [patent_app_date] => 2019-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22134 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/968696
Compositions and their use in the treatment of endometriosis and pain Feb 8, 2019 Issued
Array ( [id] => 16468160 [patent_doc_number] => 20200369697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS [patent_app_type] => utility [patent_app_number] => 16/966369 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966369 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966369
MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS Feb 7, 2019 Abandoned
Array ( [id] => 16246095 [patent_doc_number] => 10745436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Neuroactive steroids, compositions, and uses thereof [patent_app_type] => utility [patent_app_number] => 16/269779 [patent_app_country] => US [patent_app_date] => 2019-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31912 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269779 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/269779
Neuroactive steroids, compositions, and uses thereof Feb 6, 2019 Issued
Array ( [id] => 14406539 [patent_doc_number] => 20190169113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Ketamine Derivatives [patent_app_type] => utility [patent_app_number] => 16/269015 [patent_app_country] => US [patent_app_date] => 2019-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269015 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/269015
Ketamine Derivatives Feb 5, 2019 Abandoned
Array ( [id] => 17648487 [patent_doc_number] => 11351188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Folic compositions and methods for treatment of diabetic neuropathies [patent_app_type] => utility [patent_app_number] => 16/264609 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5625 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264609 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/264609
Folic compositions and methods for treatment of diabetic neuropathies Jan 30, 2019 Issued
Array ( [id] => 14649355 [patent_doc_number] => 20190231806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Metformin Compositions and Methods for Treatment of Diabetes [patent_app_type] => utility [patent_app_number] => 16/264595 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264595 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/264595
Metformin compositions and methods for treatment of diabetes Jan 30, 2019 Issued
Array ( [id] => 16621479 [patent_doc_number] => 20210040132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => NOVEL COMPOUND FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/967092 [patent_app_country] => US [patent_app_date] => 2019-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967092 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967092
Compound for preventing or treating neurodegenerative disease and application thereof Jan 28, 2019 Issued
Array ( [id] => 16540967 [patent_doc_number] => 20200407380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => ORGANOMETALLIC COMPOUNDS AND THIN FILM USING SAME [patent_app_type] => utility [patent_app_number] => 16/968492 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968492 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/968492
Organometallic compounds and thin film using same Jan 24, 2019 Issued
Menu